Shankar Musunuri, Ph.D., MBA

Shankar Musunuri, Ph.D., MBA

Chief Executive Officer, Chairman and Co-FounderatOcugen· In proxies 2022–2025

Pay in FY2025+149% from the year before · Ocugen stock +67.7% the same year

Shankar Musunuri, Ph.D., MBA was paid $4.8M in FY2025 (Dec), up 149%. Ocugen stock rose 67.7% that year.

Pay$100 in the stock at the end of FY21 → $30
Pay is from the Summary Compensation Table of each Ocugen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. OcugenPublic company · 4 yr
    • Chief Executive Officer, Chairman and Co-Founder2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Boards1

  • OcugenChair · 4 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?